Skip to main content
Equibles

Mike Ols

Analyst

Morgan Stanley

Equibles does not estimate personal net worth.

About Mike Ols

Mike Ols is recorded as Analyst at Morgan Stanley. Mike Ols has spoken on 3 earnings calls across 3 companies, most recently for Viking Therapeutics, Inc. on July 29, 2026. Those appearances were for Viking Therapeutics, Inc. (VKTX), Fractyl Health, Inc. (GUTS) and Arrowhead Pharmaceuticals, Inc. (ARWR). The companies whose calls Mike Ols spoke on are classified in the Healthcare sector.

Mike Ols on recent calls

“Maybe just a follow-up on Steve's question related to the maintenance study and specifically safety, given the fact that you might expect to see a little bit more safety events sort of in the initial titration phase, you know, but I think the focus here is really more on maintenance.”
Analyst — Morgan Stanley, Viking Therapeutics Q2 2026 Earnings Call and Webcast ·
“And maybe just to follow up on the Rejuva 001 study that you're getting underway here, can you just comment on the first dose cohort?”
Analyst — Morgan Stanley, Fractyl Health, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Morgan Stanley

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity